These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 9521734)

  • 1. Mutational analysis of posttranslational heterocycle biosynthesis in the gyrase inhibitor microcin B17: distance dependence from propeptide and tolerance for substitution in a GSCG cyclizable sequence.
    Sinha Roy R; Belshaw PJ; Walsh CT
    Biochemistry; 1998 Mar; 37(12):4125-36. PubMed ID: 9521734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Kinetics and regioselectivity of peptide-to-heterocycle conversions by microcin B17 synthetase.
    Belshaw PJ; Roy RS; Kelleher NL; Walsh CT
    Chem Biol; 1998 Jul; 5(7):373-84. PubMed ID: 9662507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cofactor requirements and reconstitution of microcin B17 synthetase: a multienzyme complex that catalyzes the formation of oxazoles and thiazoles in the antibiotic microcin B17.
    Milne JC; Roy RS; Eliot AC; Kelleher NL; Wokhlu A; Nickels B; Walsh CT
    Biochemistry; 1999 Apr; 38(15):4768-81. PubMed ID: 10200165
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The McbB component of microcin B17 synthetase is a zinc metalloprotein.
    Zamble DB; McClure CP; Penner-Hahn JE; Walsh CT
    Biochemistry; 2000 Dec; 39(51):16190-9. PubMed ID: 11123948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the microcin B17 propeptide in substrate recognition: solution structure and mutational analysis of McbA1-26.
    Roy RS; Kim S; Baleja JD; Walsh CT
    Chem Biol; 1998 Apr; 5(4):217-28. PubMed ID: 9545435
    [TBL] [Abstract][Full Text] [Related]  

  • 6. From peptide precursors to oxazole and thiazole-containing peptide antibiotics: microcin B17 synthase.
    Li YM; Milne JC; Madison LL; Kolter R; Walsh CT
    Science; 1996 Nov; 274(5290):1188-93. PubMed ID: 8895467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Posttranslational heterocyclization of cysteine and serine residues in the antibiotic microcin B17: distributivity and directionality.
    Kelleher NL; Hendrickson CL; Walsh CT
    Biochemistry; 1999 Nov; 38(47):15623-30. PubMed ID: 10569947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP/GTP hydrolysis is required for oxazole and thiazole biosynthesis in the peptide antibiotic microcin B17.
    Milne JC; Eliot AC; Kelleher NL; Walsh CT
    Biochemistry; 1998 Sep; 37(38):13250-61. PubMed ID: 9748332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Architecture of Microcin B17 Synthetase: An Octameric Protein Complex Converting a Ribosomally Synthesized Peptide into a DNA Gyrase Poison.
    Ghilarov D; Stevenson CEM; Travin DY; Piskunova J; Serebryakova M; Maxwell A; Lawson DM; Severinov K
    Mol Cell; 2019 Feb; 73(4):749-762.e5. PubMed ID: 30661981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The leader peptide is essential for the post-translational modification of the DNA-gyrase inhibitor microcin B17.
    Madison LL; Vivas EI; Li YM; Walsh CT; Kolter R
    Mol Microbiol; 1997 Jan; 23(1):161-8. PubMed ID: 9004229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The maturation pathway of microcin B17, a peptide inhibitor of DNA gyrase.
    Yorgey P; Davagnino J; Kolter R
    Mol Microbiol; 1993 Aug; 9(4):897-905. PubMed ID: 8231817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expressed protein ligation to probe regiospecificity of heterocyclization in the peptide antibiotic microcin B17.
    Roy RS; Allen O; Walsh CT
    Chem Biol; 1999 Nov; 6(11):789-99. PubMed ID: 10574779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Posttranslational modifications in microcin B17 define an additional class of DNA gyrase inhibitor.
    Yorgey P; Lee J; Kördel J; Vivas E; Warner P; Jebaratnam D; Kolter R
    Proc Natl Acad Sci U S A; 1994 May; 91(10):4519-23. PubMed ID: 8183941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A major portion of DNA gyrase inhibitor microcin B17 undergoes an N,O-peptidyl shift during synthesis.
    Ghilarov D; Serebryakova M; Shkundina I; Severinov K
    J Biol Chem; 2011 Jul; 286(30):26308-18. PubMed ID: 21628468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo processing and antibiotic activity of microcin B17 analogs with varying ring content and altered bisheterocyclic sites.
    Sinha Roy R; Kelleher NL; Milne JC; Walsh CT
    Chem Biol; 1999 May; 6(5):305-18. PubMed ID: 10322125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Maturation of Escherichia coli maltose-binding protein by signal peptidase I in vivo. Sequence requirements for efficient processing and demonstration of an alternate cleavage site.
    Fikes JD; Barkocy-Gallagher GA; Klapper DG; Bassford PJ
    J Biol Chem; 1990 Feb; 265(6):3417-23. PubMed ID: 2406254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutational analysis of potential zinc-binding residues in the active site of the enterococcal D-Ala-D-Ala dipeptidase VanX.
    McCafferty DG; Lessard IA; Walsh CT
    Biochemistry; 1997 Aug; 36(34):10498-505. PubMed ID: 9265630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The DNA replication inhibitor microcin B17 is a forty-three-amino-acid protein containing sixty percent glycine.
    Davagnino J; Herrero M; Furlong D; Moreno F; Kolter R
    Proteins; 1986 Nov; 1(3):230-8. PubMed ID: 3329729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Microbial Toxin Microcin B17: Prospects for the Development of New Antibacterial Agents.
    Collin F; Maxwell A
    J Mol Biol; 2019 Aug; 431(18):3400-3426. PubMed ID: 31181289
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MBP fusion protein with a viral protease cleavage site: one-step cleavage/purification of insoluble proteins.
    Alexandrov A; Dutta K; Pascal SM
    Biotechniques; 2001 Jun; 30(6):1194-8. PubMed ID: 11414203
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.